methylprednisolone acetate has been researched along with Pleural Effusion, Malignant in 2 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Pleural Effusion, Malignant: Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
North, SA | 1 |
Au, HJ | 1 |
Halls, SB | 1 |
Tkachuk, L | 1 |
Mackey, JR | 1 |
Bartal, AH | 1 |
Gazitt, Y | 1 |
Zidan, G | 1 |
Vermeulen, B | 1 |
Robinson, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Retrospective Study of Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome[NCT01423864] | Phase 2 | 29 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for methylprednisolone acetate and Pleural Effusion, Malignant
Article | Year |
---|---|
A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion.
Topics: Anti-Inflammatory Agents; Breast Neoplasms; Double-Blind Method; Female; Humans; Instillation, Drug; | 2003 |
1 other study available for methylprednisolone acetate and Pleural Effusion, Malignant
Article | Year |
---|---|
Clinical and flow cytometry characteristics of malignant pleural effusions in patients after intracavitary administration of methylprednisolone acetate.
Topics: Adult; Aged; Anti-Inflammatory Agents; Breast Neoplasms; Carcinoma; Cryopreservation; DNA, Neoplasm; | 1991 |